Literature DB >> 3073623

Recto-vaginal colonization and urinary tract infection by group B Streptococcus in the pregnant diabetic patient.

R Matorras1, A Garcia-Perea, J A Usandizaga, F Omeñaca.   

Abstract

The influence of maternal diabetes on Group B Streptococcus (GBS) colonization and GBS urinary infection was investigated. The population under study comprised 1,050 pregnant women (70 of them diabetics, the remaining 980 non-diabetics). A higher prevalence of GBS colonization was found among diabetics (20% versus 10.9%) (p less than 0.05). The rate of colonization was not correlated to the severity of the diabetes condition. Urinary infection was diagnosed on 8.6% of diabetic patients, versus 7.1% of non-diabetics (p greater than 0.05). Urinary infection by GBS occurred with similar frequency in both groups (0% in diabetics and 1% in non-diabetics). The possible etiological implications are commented on, and vaginal and rectal cultures are recommended for GBS screening in the pregnant diabetic patient.

Entities:  

Mesh:

Year:  1988        PMID: 3073623     DOI: 10.3109/00016348809004274

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  3 in total

Review 1.  Group B streptococcal infection of the genitourinary tract in pregnant and non-pregnant patients with diabetes mellitus: An immunocompromised host or something more?

Authors:  Lynsa M Nguyen; Joel I Omage; Kristen Noble; Kelsey L McNew; Daniel J Moore; David M Aronoff; Ryan S Doster
Journal:  Am J Reprod Immunol       Date:  2021-10-19       Impact factor: 3.886

2.  Evaluation of vaginal group B streptococcal culture results after digital vaginal examination and its pattern of antibiotic resistance in pregnant women.

Authors:  Khadijeh Nasri; Ali Chehrei; Mahdokht Sadat Manavi
Journal:  Iran J Reprod Med       Date:  2013-12

3.  Host Cathelicidin Exacerbates Group B Streptococcus Urinary Tract Infection.

Authors:  Kathryn A Patras; Alison Coady; Priyanka Babu; Samuel R Shing; Albert D Ha; Emma Rooholfada; Stephanie L Brandt; Matthew Geriak; Richard L Gallo; Victor Nizet
Journal:  mSphere       Date:  2020-04-22       Impact factor: 4.389

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.